Brugada syndrome: Current clinical aspects and risk stratification

Annals of Noninvasive Electrocardiology

Volumn 7, Issue 3, 2002, Pages 251-262

  Ikeda, Takanori ^a  

^a TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

Author keywords

Brugada syndrome; Electrophysiological study; Risk stratification; Signal averaged electrocardiography; Sudden cardiac death; Ventricular fibrillation

Indexed keywords

ION CHANNEL;

ADRENERGIC SYSTEM; ADULT; BRUGADA SYNDROME; DEFIBRILLATOR; DIAGNOSTIC ACCURACY; ELECTROCARDIOGRAM; ELECTRON BEAM TOMOGRAPHY; ELECTROPHYSIOLOGY; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SIGNAL AVERAGED ELECTROCARDIOGRAPHY; ST SEGMENT ELEVATION; SUDDEN DEATH; VAGUS NERVE STIMULATION;

EID: 0036636331     PISSN: 1082720X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2002.tb00172.x     Document Type: Review

References (72)

1. Right bundle branch block, persistent ST-segment elevation and sudden cardiac death. A distinct clinical and electrocardiographic syndrome
2. The Brugada syndrome
3. Brugada syndrome as a cause of sudden cardiac death in children
4. "Brugada" syndrome. Clinical data and suggested pathophysiological mechanism
5. The Brugada syndrome. Clinical, electrophysiological and genetic aspects
6. Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation
7. Ventricular fibrillation in a patient with prominent J (Osborn) waves and ST-segment elevation in the inferior electrocardiographic leads. A Brugada syndrome variant?
8. Clinical characteristics of patients with spontaneous or inducible ventricular fibrillation without apparent heart disease presenting with J wave and ST-segment elevation in inferior leads
9. Brugada syndrome and supraventricular tachyarrhythmias. A novel association?
10. Prevalence of the Brugada syndrome in an apparently healthy population
11. Prevalence of the Brugada signs in idiopathic ventricular fibrillation and healthy controls
12. Two-year case collection of the Brugada syndrome electrocardiogram pattern at a large teaching hospital
13. Prevalence and mortality of the Brugada-type electrocardiogram in one city in Japan
14. The prevalence, incidence and prognostic value of the Brugada-type electrocardiogram: A population-based study of four decades
15. Prevalence of asymptomatic ST-segment elevation in the right precordial leads with right bundle branch block (Brugada-type ST shift) among the general Japanese population
16. Prognostic value of electrophysiologic investigations in Brugada syndrome
17. Foretelling the future in Brugada syndrome. Do we have the crystal ball?
18. Assessment of non-invasive markers in identifying patients at risk in the Brugada syndrome. Insight into risk stratification
19. The Brugada syndrome. Diagnostic criteria and cellular mechanism
20. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts
21. Autonomic and antiarrhythmic drug modulation of ST-segment elevation in patients with Brugada syndrome
22. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease
23. ST segment elevation induced by class IC antiarrhythmic agents: Underlying electrophysiologic mechanisms and insights into drug-induced proarrhythmia
24. ST-segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs. Insight into the mechanism of Brugada syndrome
25. Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome. Clinical implication of eight-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms
26. Aborted sudden death, transient Brugada pattern and wide QRS dysrrhythmias after massive cocaine ingestion
27. Asymptomatic Brugada syndrome case of unmasking during dimenhydrinate infusion
28. Arrhythmogenic marker for the sudden death unexplained death syndrome in Thai men
29. Dynamic changes of 12-lead electrocardiograms in a patient with Brugada syndrome
30. Spatial and temporal heterogeneity of depolarization and repolarization may complicate implantable cardioverter defibrillator therapy in Brugada syndrome
31. Prevention of ventricular fibrillation by pacing in a man with Brugada syndrome
32. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation
33. Familial sudden cardiac death associated with a terminal QRS abnormality on a surface 12-lead electrocardiogram in the index case
34. Quinidine-induced electrocardiographic normalization in two patients with Brugada syndrome
35. New electrocardiographic leads the procainamide test for the detection of the Brugada sign in sudden unexplained death syndrome survivors and their relatives
36. Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation
37. 3. A marker for sudden death in patients without demonstrable structural heart disease
38. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome. A prospective evaluation of 52 families
39. Infant case with a malignant form of Brugada syndrome
40. Right bundle branch block, right precordial ST-segment elevation and sudden death in young people
41. 3
42. Three-year follow-up of patients with right bundle branch block and ST segment elevation in the right precordial leads: Japanese registry of Brugada syndrome
43. Relatively benign clinical course in asymptomatic patients with Brugada-type electrocardiogram without family history of sudden death
44. Brugada syndrome. Why are there multiple answers to a simple question?
45. Spontaneous episode of polymorphic ventricular tachycardia in a patient with intermittent Brugada syndrome
46. Natural history of Brugada syndrome. Insights for risk stratification and management
47. Spontaneous sustained monomorphic ventricular tachycardia in a patient with Brugada syndrome
48. Spontaneous right ventricular outflow tract tachycardia in a patient with Brugada syndrome
49. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome
50. Syncope in pharmacologically unmasked Brugada syndrome. Indication for an implantable defibrillator or an unresolved dilemma?
51. Arrhythmias in patients with Brugada-type electrocardiographic findings
52. Cardiac autonomic dysfunction in Brugada syndrome
53. Familial occurrence of electrocardiographic abnormalities of the Brugada-type
54. Clinical diagnosis and risk stratification in patients with Brugada syndrome
55. ST-segment and T-wave alternans in a patient with Brugada syndrome
56. Intravenous administration of class I antiarrhythmic drugs induced T wave alternans in a patient with Brugada syndrome
57. Localized right ventricular morphological abnormalities detected by electron-beam computed tomography represent arrhythmogenic substrates in patients with the Brugada syndrome
58. "Localized" right ventricular morphological abnormalities in patients with the Brugada syndrome. What is their significance?
59. Mode of induction of ventricular tachyarrhythmias in Brugada syndrome
60. SCN5A mutations associated with an inherited cardiac arrhythmia, long-QT syndrome
61. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent
62. + channel mutation causing both long-QT and Brugada syndromes
63. Cardiac Na(+) channel dysfunction in Brugada syndrome is aggravated by beta(1)-subunit
64. + channel
65. Enhanced sodium channel intermediate activation in Brugada syndrome
66. Novel mechanism for Brugada syndrome. Defective surface localization of an SCN5A mutant (R1432G)
67. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes
68. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family
69. The syndrome of right bundle branch block, ST segment elevation in V1 to V3 and sudden death. The Brugada syndrome
70. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy
71. Task force on sudden cardiac death of the European Society of Cardiology
72. Effects of electrophysiologic-guided therapy with class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome